OPEN ACCESS
The rapid advancements in molecular biotechnology have ushered in a new era of healthcare, characterized by unprecedented precision, personalization, and efficacy in disease prevention, diagnosis, and treatment. This review article explores the transformative role of molecular biotechnology in healthcare, highlighting key innovations such as CRISPR-Cas9 gene editing, next-generation sequencing, and synthetic biology. By delving into the mechanisms and applications of these technologies, we illustrate how they are reshaping the landscape of medicine. The integration of molecular biotechnology into clinical practice promises to enhance therapeutic outcomes, reduce healthcare costs, and address previously insurmountable medical challenges. This article also examines the ethical, regulatory, and societal implications of these advancements, emphasizing the need for a balanced approach to harness their full potential responsibly. Through a comprehensive analysis of current trends and future prospects, we aim to underscore the pivotal role of molecular biotechnology in pioneering healthcare solutions that are both innovative and sustainable.